SCHEMBL2859196

SCHEMBL2859196

CCOC(=O)c1ccc(N2CCN(CCCCC(N)C(=O)N3CCSC3)CC2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.47
DPP7 Q9UHL4 5/20 0.44
DPP4 P27487 5/20 0.44
DPP8 Q6V1X1 2/20 0.44
DPP9 Q86TI2 2/20 0.44
HRH3 Q9Y5N1 2/20 0.44
OGA O60502 1/20 0.43
HRH2 P25021 2/20 0.39
HRH1 P35367 2/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
USP30 Q70CQ3 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859190 1.00 P2RY12 (0.47) P2RY12DPP7DPP4DPP8DPP9
SCHEMBL2855994 0.88 DPP4 (0.48) DPP7DPP4DPP8DPP9HRH3
SCHEMBL2855997 0.88 DPP4 (0.48) DPP7DPP4DPP8DPP9HRH3
SCHEMBL2856003 0.88 DPP4 (0.48) DPP7DPP4DPP8DPP9HRH3
SCHEMBL2856012 0.88 DPP4 (0.48) DPP7DPP4DPP8DPP9HRH3
SCHEMBL2881885 0.81 DPP4 (0.51) DPP7DPP4DPP8DPP9MEN1
SCHEMBL2856473 0.81 DPP4 (0.51) DPP7DPP4DPP8DPP9
SCHEMBL2881880 0.81 DPP4 (0.51) DPP7DPP4DPP8DPP9MEN1
SCHEMBL2856470 0.81 DPP4 (0.51) DPP7DPP4DPP8DPP9
SCHEMBL2856428 0.80 DPP4 (0.51) DPP7DPP4DPP8DPP9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790725-B2 Thiazolidine derivatives and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-09-07 US disclosed
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORPORATION (JP) 2007-11-08 US disclosed
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2004-12-23 US disclosed
EP-1426366-A1 THIAZOLIDINE DERIVATIVE AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF DPP4, DPP7, DPP3 P2RY12 1696/4885DPP7 2/4885DPP4 1/4885
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof DPP4, DPP7, DPP3 P2RY12 2293/4885DPP7 2/4885DPP4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.